Skip to main content
Journal cover image

Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma.

Publication ,  Journal Article
Heimberger, AB; Crotty, LE; Archer, GE; McLendon, RE; Friedman, A; Dranoff, G; Bigner, DD; Sampson, JH
Published in: J Neuroimmunol
February 1, 2000

To evaluate the efficacy and toxicity of dendritic cell (DC) based therapy for intracerebral gliomas, we utilized a cell line derived from an astrocytoma that arose spontaneously in a VM/Dk mouse. This astrocytoma mirrors human gliomas phenotypically, morphologically and secretes transforming growth factor (TGF)-betas, immunosuppressive cytokines secreted by human gliomas. Systemic vaccination of mice with DCs pulsed with tumor homogenate followed by intracranial tumor challenge produced a > 160% increase in median survival (p = 0.016) compared with mice vaccinated with PBS or unpulsed DCs (p = 0.083). Fifty percent of mice treated with pulsed DCs survived long-term. Immunologic memory was demonstrated by survival of mice rechallenged with tumor. Both cell-mediated and humoral immunity was induced. On histological examination only focal areas of demyelination at the tumor implantation site were present. There was no evidence that autoimmune encephalomyelitis was induced by DC vaccination. Therefore, in a murine model, vaccination with DCs pulsed with glioma tumor homogenate is a safe and effective therapy against a syngeneic glioma located in the immunologically privileged central nervous system (CNS).

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Neuroimmunol

DOI

ISSN

0165-5728

Publication Date

February 1, 2000

Volume

103

Issue

1

Start / End Page

16 / 25

Location

Netherlands

Related Subject Headings

  • Vaccination
  • Tumor Cells, Cultured
  • T-Lymphocytes, Cytotoxic
  • Neurology & Neurosurgery
  • Mice
  • Glioma
  • Encephalomyelitis, Autoimmune, Experimental
  • Dendritic Cells
  • Brain Neoplasms
  • Bone Marrow Cells
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Heimberger, A. B., Crotty, L. E., Archer, G. E., McLendon, R. E., Friedman, A., Dranoff, G., … Sampson, J. H. (2000). Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma. J Neuroimmunol, 103(1), 16–25. https://doi.org/10.1016/s0165-5728(99)00172-1
Heimberger, A. B., L. E. Crotty, G. E. Archer, R. E. McLendon, A. Friedman, G. Dranoff, D. D. Bigner, and J. H. Sampson. “Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma.J Neuroimmunol 103, no. 1 (February 1, 2000): 16–25. https://doi.org/10.1016/s0165-5728(99)00172-1.
Heimberger AB, Crotty LE, Archer GE, McLendon RE, Friedman A, Dranoff G, et al. Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma. J Neuroimmunol. 2000 Feb 1;103(1):16–25.
Heimberger, A. B., et al. “Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma.J Neuroimmunol, vol. 103, no. 1, Feb. 2000, pp. 16–25. Pubmed, doi:10.1016/s0165-5728(99)00172-1.
Heimberger AB, Crotty LE, Archer GE, McLendon RE, Friedman A, Dranoff G, Bigner DD, Sampson JH. Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma. J Neuroimmunol. 2000 Feb 1;103(1):16–25.
Journal cover image

Published In

J Neuroimmunol

DOI

ISSN

0165-5728

Publication Date

February 1, 2000

Volume

103

Issue

1

Start / End Page

16 / 25

Location

Netherlands

Related Subject Headings

  • Vaccination
  • Tumor Cells, Cultured
  • T-Lymphocytes, Cytotoxic
  • Neurology & Neurosurgery
  • Mice
  • Glioma
  • Encephalomyelitis, Autoimmune, Experimental
  • Dendritic Cells
  • Brain Neoplasms
  • Bone Marrow Cells